Ropinirole 0.5 mg Tablet PCD Franchise in Ahmedabad

Parkinson’s Disease Medicine Supplier in Hyderabad

Neurology Drug Distributor in Kolkata

CNS Pharma Franchise Opportunity in Chennai

Ropinirole 0.5 Tablet Stockist in Bangalore
Neuro Range Medicine Export and Manufacturing in Chandigarh

Home/Products /ropinirole-0-5-mg-tablet

Ropinole 0.5 Tablet

Composition : Ropinirole (0.5mg) Tablet

Dosage Form : Tablet

Packaging Type : Blister

Packaging : 10*10

Price : ₹1/-

Ropinole 0.5 Tablet contains Ropinirole 0.5mg, a dopamine agonist used in the management of Parkinson’s disease and restless leg syndrome (RLS). It helps improve motor function by stimulating dopamine receptors in the brain, reducing symptoms such as tremors, muscle stiffness, slow movement, and leg discomfort during rest.

This medication is commonly used as monotherapy in early Parkinson’s or in combination therapy during advanced treatment stages. Its role in improving mobility and quality of life makes it a widely prescribed drug in neurological care.

Belonging to the neurology and CNS therapeutic segment, Ropinole 0.5 Tablet is frequently prescribed by neurologists and movement disorder specialists. Its chronic prescription nature ensures steady demand across hospitals, neurological centers, and pharmacy networks.

For PCD franchise owners, wholesalers, and export buyers, this product offers a profitable opportunity within the growing neuro segment. It is available for bulk orders, private-label third-party manufacturing, institutional supply, and export logistics support across India.

Read More

About the Product

Ropinole 0.5 Tablet contains Ropinirole 0.5mg, a dopamine agonist used in the management of Parkinson’s disease and restless leg syndrome (RLS). It helps improve motor function by stimulating dopamine receptors in the brain, reducing symptoms such as tremors, muscle stiffness, slow movement, and leg discomfort during rest.

This medication is commonly used as monotherapy in early Parkinson’s or in combination therapy during advanced treatment stages. Its role in improving mobility and quality of life makes it a widely prescribed drug in neurological care.

Belonging to the neurology and CNS therapeutic segment, Ropinole 0.5 Tablet is frequently prescribed by neurologists and movement disorder specialists. Its chronic prescription nature ensures steady demand across hospitals, neurological centers, and pharmacy networks.

For PCD franchise owners, wholesalers, and export buyers, this product offers a profitable opportunity within the growing neuro segment. It is available for bulk orders, private-label third-party manufacturing, institutional supply, and export logistics support across India.

Common side effects include drowsiness, dizziness, weight gain, increased appetite, dry mouth, constipation, and sleep disturbances; less commonly patients may experience extrapyramidal symptoms (movement disorders), elevated prolactin levels, metabolic changes (weight/BG/lipids), or orthostatic dizziness — seek medical help for severe symptoms.

Risplom 4 Tablet is indicated for the treatment of schizophrenia, bipolar disorder (acute mania and maintenance), irritability associated with autism spectrum disorder, and behavioural disturbances related to psychosis; it helps reduce aggression, severe anxiety-driven behaviours, hallucinations, and disorganized thought.

Take Risplom 4 Tablet exactly as prescribed and do not stop it abruptly; inform your doctor about heart disease, diabetes, liver or kidney problems, a history of seizures, or pregnancy; avoid alcohol and activities requiring alertness until you know how it affects you; regular monitoring (weight, glucose, lipids, and movement symptoms) may be required.

Store Risplom 4 Tablet in a cool, dry place below 25°C, away from direct sunlight and moisture. Keep out of reach of children.

Get in Touch

Regulatory Compliance & Professional Verification

This catalog is a digital representation of the Cafoli Lifecare portfolio and is intended for use by authorized pharmaceutical distributors and PCD franchise partners.

  • No Consumer Sale: We do not entertain retail inquiries or direct sales to patients.
  • Information Accuracy: While we strive for accuracy, product availability, packaging, and regulatory status may change based on CDSCO guidelines and state-specific drug laws.
  • Medical Advice: Patients are strictly advised not to self-medicate or use this information for treatment. Always consult a qualified medical practitioner.
  • Licensing: All business associations are subject to the submission of valid GST and Drug License (DL) documentation.

Strategic Advisory

Ms. Shiwani Dhiman

VP-Strategic Outreach & Engagement

Ms. Shiwani specializes in market outreach and strategic partnership orchestration for entrepreneurs building scalable PCD Pharma Franchise models.

View Professional Profile

Start Your Journey

Partner With Cafoli

Ready to Dominate your territory with a Monopoly-Based PCD Franchise? Join our rapidly growing network of successful franchise partners and turn your ambitions into reality. Limited Territories Available — Don’t Miss Out!

Quick Navigation